Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Polis

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Nature Medicine|July 14, 1998
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adultsR E Walker, C S Carter, L Muul, et al.
Archives of Internal Medicine|May 20, 1998
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USAR J Whitley, M A Jacobson, D N Friedberg, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patientsR T Davey, D G Chaitt, G F Reed, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1999
Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infectionZ Q Zhang, T Schuler, W Cavert, et al.
JAMA|November 30, 1999
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitisS M Whitcup, E Fortin, A S Lindblad, et al.
Epidemiology and Infection|January 16, 2018
Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, MaliB Kone, Y S Sarro, M Maiga, et al.
The Journal of Experimental Medicine|December 19, 2001
Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIVJ A Kovacs, R A Lempicki, I A Sidorov, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionR T Davey, N Bhat, C Yoder, et al.
BMC Infectious Diseases|November 30, 2016
Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014B Diarra, D Goita, S Tounkara, et al.
Blood|July 11, 2000
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infectionR E Walker, C M Bechtel, V Natarajan, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Nature Medicine|July 14, 1998
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adultsR E Walker, C S Carter, L Muul, et al.
Archives of Internal Medicine|May 20, 1998
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USAR J Whitley, M A Jacobson, D N Friedberg, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patientsR T Davey, D G Chaitt, G F Reed, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1999
Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infectionZ Q Zhang, T Schuler, W Cavert, et al.
JAMA|November 30, 1999
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitisS M Whitcup, E Fortin, A S Lindblad, et al.
Epidemiology and Infection|January 16, 2018
Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, MaliB Kone, Y S Sarro, M Maiga, et al.
The Journal of Experimental Medicine|December 19, 2001
Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIVJ A Kovacs, R A Lempicki, I A Sidorov, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionR T Davey, N Bhat, C Yoder, et al.
BMC Infectious Diseases|November 30, 2016
Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014B Diarra, D Goita, S Tounkara, et al.
Blood|July 11, 2000
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infectionR E Walker, C M Bechtel, V Natarajan, et al.
Pageof 8